Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 4
Submit an article Journal homepage
285
Views
5
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients

Dong-Dong WangDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; ORCID Iconhttp://orcid.org/0000-0002-4019-5530View further author information
ORCID Icon,
Qiao-Feng YeDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; View further author information
,
Xiao ChenDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; View further author information
,
Hong XuDepartment of Nephrology, Children’s Hospital of Fudan University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Zhi-Ping LiDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6194-023XView further author information
ORCID Icon
Pages 435-441 | Received 12 Jun 2019, Accepted 30 Jul 2019, Published online: 14 Aug 2019

References

  • Anderson BJ, Holford NH. (2008). Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 48:303–32.
  • Bergsten E, Horne A, Arico M, et al. (2017). Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 130:2728–38.
  • Ehl S, Astigarraga I, von Bahr Greenwood T, et al. (2018). Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract 6:1508–17.
  • Fruit D, Rousseau A, Amrein C, et al. (2013). Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients. Clin Pharmacokinet 52:277–88.
  • Gregory J, Greenberg J, Basu S. (2019). Outcomes analysis of children diagnosed with hemophagocytic lymphohistiocytosis in the PICU. Pediatr Crit Care Med 20:e185–90.
  • Henter J-I, Elinder G, Söder O, Öst ÅKE. (1991). Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80:428–35.
  • Ishii E. (2016). Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr 4:47.
  • Ishii E, Ohga S, Imashuku S, et al. (2007). Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86:58–65.
  • Kauffman RE, Kearns GL. (1992). Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet 23:10–29.
  • Loechelt BJ, Egeler M, Filipovich AH, et al. (1994). Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL). Med Pediatr Oncol 22:325–8.
  • Marsot A, Michel F, Chasseloup E, et al. (2017). Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model. Fundam Clin Pharmacol 31:558–66.
  • Morimoto A, Nakazawa Y, Ishii E. (2016). Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int 58:817–25.
  • Ni SQ, Zhao W, Wang J, et al. (2013). Population pharmacokinetics of ciclosporin in Chinese children with aplastic anemia: effects of weight, renal function and stanozolol administration. Acta Pharmacol Sin 34:969–75.
  • Rouphael NG, Talati NJ, Vaughan C, et al. (2007). Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7:814–22.
  • Stephan JL, Donadieu J, Ledeist F, et al. (1993). Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 82:2319–23.
  • Thompson PA, Allen CE, Horton T, et al. (2009). Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 52:621–5.
  • Trottestam H, Horne A, Arico M, et al. (2011). Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118:4577–84.
  • Vadcharavivad S, Praisuwan S, Techawathanawanna N, et al. (2016). Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations. J Clin Pharm Ther 41:310–28.
  • Wang D, Chen X, Li Z. (2019a). Cyclosporin population pharmacokinetics in pediatric refractory nephrotic syndrome based on real-world studies: effects of body weight and spirolactone administration. Exp Ther Med 17:3015–20.
  • Wang DD, Chen X, Li ZP. (2019b). Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: a retrospective study. J Clin Pharm Ther 44:611.
  • Wang D, Chen X, Xu H, Li Z. (2019c). Population pharmacokinetics and dosing regimen optimisation of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients. Xenobiotica 1–8.
  • Wang DD, Lu JM, Li Q, Li ZP. (2018a). Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. J Clin Pharm Ther 43:476–83.
  • Wang DD, Lu JM, Li YZ, et al. (2018b). Population pharmacokinetics of sirolimus in pediatric tuberous sclerosis complex: from Real World Study. Int J Clin Exp Med 11:12302–9.
  • Wilhelm AJ, de Graaf P, Veldkamp AI, et al. (2012). Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy. Br J Clin Pharmacol 73:553–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.